In recent years, the pharmaceutical industry has moved away from its traditional sales model based solely on physicians' relationships with their sales reps to a multi-stakeholder influencer model. What are the key elements of the new Commercial Model? How has this new Commercial Model progressed? Is the new Commercial Model having a positive impact on physician relationships? Which companies are seeing the greatest impact on their customers?
These were some of the questions addressed in an webinar presented by Kantar Health, a leading healthcare-focused global consultancy and marketing insights company.
This article features a summary of the much anticipated NEW TRI*M™ annual survey results with physicians across the U.S. and Europe on their service expectations -- plus how they rate 16 Pharma companies on reps, relationships and services. The survey looked not only at PCPs/GPs but also -- for the first time -- at what oncologists expect from the industry.
- 2010 TRI*M™ Pharma Reputation Index
- PCP Sales Relationship Building Performance
- PCP Sales Support Performance
- TRI*M™ Drivers for Oncologists
- Key PCP WOM Trends in 2010
- Oncologist WOM Findings
- Variations by Market
- Variations by Company